Bridgeway Capital Management’s Alimera Sciences ALIM Stock Holding History

Bridgeway Capital Management’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-139,100	Closed	-$773K	–	1340
2024 Q2	$773K	Hold	139,100	–	–	0.02%	758
2024 Q1	$542K	Buy	139,100 +119,100	+596%	+$453K	0.01%	903
2023 Q4	$86.4K	Hold	20,000	–	–	﹤0.01%	1260
2023 Q3	$62K	Sell	20,000 -18,300	-48%	-$60.5K	﹤0.01%	1283
2023 Q2	$112K	Buy	38,300 +20,000	+109%	+$45.9K	﹤0.01%	1244
2023 Q1	$37.9K	Hold	18,300	–	–	﹤0.01%	1329
2022 Q4	$49.6K	Hold	18,300	–	–	﹤0.01%	1295
2022 Q3	$93K	Hold	18,300	–	–	﹤0.01%	1288
2022 Q2	$100K	Hold	18,300	–	–	﹤0.01%	1223
2022 Q1	$102K	Hold	18,300	–	–	﹤0.01%	1258
2021 Q4	$94K	Sell	18,300 -20,000	-52%	-$97.9K	﹤0.01%	1225
2021 Q3	$163K	Hold	38,300	–	–	﹤0.01%	1217
2021 Q2	$349K	Buy	38,300 +2,333	+6%	+$22.9K	0.01%	1174
2021 Q1	$346K	Hold	35,967	–	–	0.01%	1198
2020 Q4	$152K	Buy	35,967 +2,781	+8%	+$12.5K	﹤0.01%	1238
2020 Q3	$161K	Buy	33,186 +7,200	+28%	+$42.3K	﹤0.01%	1203
2020 Q2	$164K	Hold	25,986	–	–	﹤0.01%	1176
2020 Q1	$100K	Hold	25,986	–	–	﹤0.01%	1175
2019 Q4	$197K	Sell	25,986 -2	-0%	-$12	﹤0.01%	1197
2019 Q3	$221K	Sell	25,988 -13,334	-34%	-$121K	﹤0.01%	1164
2019 Q2	$525K	Hold	39,322	–	–	0.01%	964
2019 Q1	$625K	Buy	39,322 +6,667	+20%	+$101K	0.01%	954
2018 Q4	$352K	Hold	32,655	–	–	﹤0.01%	1096
2018 Q3	$480K	Hold	32,655	–	–	﹤0.01%	1153
2018 Q2	$479K	Sell	32,655 -6,667	-17%	-$93.7K	﹤0.01%	1150
2018 Q1	$608K	Hold	39,322	–	–	0.01%	1033
2017 Q4	$784K	Hold	39,322	–	–	0.01%	938
2017 Q3	$796K	Buy	39,322 +13,334	+51%	+$285K	0.01%	932
2017 Q2	$542K	Sell	25,988 -15,630	-38%	-$335K	0.01%	1064
2017 Q1	$874K	Buy	41,618 +23,333	+128%	+$449K	0.01%	862
2016 Q4	$296K	Hold	18,285	–	–	﹤0.01%	1222
2016 Q3	$409K	Buy	18,285 +4,014	+28%	+$92.4K	0.01%	1158
2016 Q2	$263K	Sell	14,271 -4,000	-22%	-$106K	﹤0.01%	1245
2016 Q1	$480K	Hold	18,271	–	–	0.01%	1073
2015 Q4	$663K	Hold	18,271	–	–	0.01%	944
2015 Q3	$606K	Buy	18,271 +8,189	+81%	+$461K	0.01%	946
2015 Q2	$697K	Hold	10,082	–	–	0.01%	925
2015 Q1	$758K	Hold	10,082	–	–	0.02%	912
2014 Q4	$838K	Hold	10,082	–	–	0.02%	838
2014 Q3	$820K	Hold	10,082	–	–	0.02%	837
2014 Q2	$904K	Hold	10,082	–	–	0.02%	811
2014 Q1	$1.19M	Hold	10,082	–	–	0.03%	689
2013 Q4	$711K	Hold	10,082	–	–	0.02%	882
2013 Q3	$569K	Buy	10,082 +307	+3%	+$19.3K	0.02%	965
2013 Q2	$716K	Buy	+9,775	New	+$564K	0.03%	778

Bridgeway Capital Management's ALIM Position: Q3 2024 in Review

Bridgeway Capital Management sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 139,100 shares — an estimated $773K sold.

Bridgeway Capital Management first reported a position in ALIM in Q2 2013 and held it in 45 quarters. The position peaked at $1.19M in Q1 2014. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.

Bridgeway Capital Management reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
Bridgeway Capital Management sold 139,100 Alimera Sciences shares in Q3 2024, an estimated $773K.
Bridgeway Capital Management first reported a position in Alimera Sciences in Q2 2013 and held it in 45 quarters.
Bridgeway Capital Management's Alimera Sciences position peaked at $1.19M in Q1 2014.
0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.

Based on Bridgeway Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.